Tuberculosis (TB) is the world's biggest infectious disease killer with multidrug-resistant TB (MDR-TB) posing a particular threat to global health. A study shows that resistance to the new MDR-TB ...

I hope I got your attention with my last post about the Pacific Health Summit and the acute global threat of Multi-Drug Resistant Tuberculosis (MDR-TB). All of the issues around innovation in public ...

Please provide your email address to receive an email when new articles are posted on . The National Institute of Allergy and Infectious Diseases, part of the NIH, has launched a trial investigating ...

FRANKLIN LAKES, N.J., April 13, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its BD MAXTM Molecular Multi-Drug ...

There were an estimated 490,000 new cases of drug-resistant TB in 2016. Tuberculosis, a lung disease most often transmitted by breathing infected particles in the air, is the ninth leading cause of ...

New WHO recommendations aim to speed up detection and improve treatment outcomes for multidrug resistant tuberculosis (MDR-TB) through use of a novel rapid diagnostic test and a shorter, cheaper ...

SMSR & Sharda University set up Centre for Drug Quantification and Therapeutic Drug Monitoring to strengthen MDR-TB care: Our Bureau, Bengaluru Thursday, February 19, 2026, 14:45 ...

A new partnership announced today will increase efforts to coordinate the development of complementary novel tools to fight TB, including drug-resistant TB, and identify emerging drug resistance ...

The public has been urged to undergo early screening for tuberculosis (TB) and adopt a healthy lifestyle to maintain optimal immunity and prevent ...

Last month I attended the Pacific Health Summit in Seattle. It is a pretty exclusive venue (aspiring to be the “Davos of Health Care”) attended by senior representatives from the world of health care ...